How have I shares performed in 2024?

Intellipharmaceutics International's stock was trading at C$3.23 at the beginning of the year. Since then, I stock has increased by 0.0% and is now trading at C$3.23. View the best growth stocks for 2024 here .

When is Intellipharmaceutics International's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, June 4th 2024. View our I earnings forecast .

What other stocks do shareholders of Intellipharmaceutics International own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Intellipharmaceutics International investors own include QuickLogic (QUIK) , VBI Vaccines (VBIV) , NeuLion (NLN) , Micron Technology (MU) , Mallinckrodt (MNK) , Intellipharmaceutics International (IPCIF) , Fitbit (FIT) , Clean Commodities (CLE) , Calithera Biosciences (CALA) and BlackBerry (BB) .

How do I buy shares of Intellipharmaceutics International?

Shares of I stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor , Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers. Compare Top Brokerages Here .

TSE:I

Intellipharmaceutics International (I) Stock Price, News & Analysis

→ Nerd Investor Reveals Secret To Make Money With A.I. (From InvestorPlace) (Ad)

Free I Stock Alerts

C$3.23

+0.04 (+1.25%)

(As of 03/17/2017)

Compare

Today's Range: C$3.15
▼
C$3.26
50-Day Range: C$3.23
▼
C$3.23
52-Week Range: C$1.78
▼
C$4.50

Volume: 7,625 shs
Average Volume: 16,872 shs
Market Capitalization: C$97.40 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis

Get Intellipharmaceutics International alerts:

Ad InvestorPlace

A.I. “Perfect Storm” Could Send THESE Stocks Sky High

A little-known investment analyst whose performance beat out 15,000+ other experts in 2020 has identified an opportunity in the A.I. space. He's calling it A.I.'s perfect storm.

>>Check out what this A.I. Perfect Storm is<<

About Intellipharmaceutics International

Intellipharmaceutics International Inc is a Canada-based pharmaceutical company engaged in the research, development and manufacture of controlled-release and targeted-release oral solid dosage drugs. Its Hypermatrix technology is a multidimensional controlled-release drug delivery platform that is applied to the development of a range of existing and new pharmaceuticals. Based on this technology platform, it has developed various drug delivery systems and a pipeline of products, and product candidates in various stages of development, in therapeutic areas that include neurology and cardiovascular. Its pipeline of products includes Rexista Oxycodone, Regabatin XR, Generic Focalin XR, Generic Effexor XR, Generic Protonix, Generic Glucophage XR, Generic Seroquel XR, Generic Lamictal XR, Generic Keppra XR, Generic Pristiq and Generic Ranexa. Its generic product candidates also include Trazodone hydrochloride extended-release tablets and Carvedilol phosphate extended-release capsules.

I Stock Price History

30 days | 90 days | 365 days | Advanced Chart

I Stock News Headlines

February 19, 2024 | theglobeandmail.com

IntelliPharmaCeutics Intl: Top 10 Undervalued Biotechnology Industry Stocks (IPCI)

January 3, 2024 | theglobeandmail.com

Closing Bell: Intellipharmaceutics International Inc up on Wednesday (IPCI)

April 16, 2024 | InvestorPlace (Ad)

Nerd Investor Reveals Secret To Make Money With A.I.

He's doing something he's never done before. In ten years, this nerd investor has picked 210+ stocks that have gone up at least 100%.

December 7, 2023 | theglobeandmail.com

Closing Bell: Intellipharmaceutics International Inc up on Tuesday (IPCI)

October 16, 2023 | msn.com

Intellipharmaceutics International GAAP EPS of -$0.06

October 13, 2023 | theglobeandmail.com

Closing Bell: Intellipharmaceutics International Inc down on Friday (IPCI)

July 6, 2023 | theglobeandmail.com

Closing Bell: Intellipharmaceutics International Inc down on Wednesday (IPCI)

June 29, 2023 | theglobeandmail.com

Closing Bell: Intellipharmaceutics International Inc down on Tuesday (IPCI)

April 16, 2024 | InvestorPlace (Ad)

Nerd Investor Reveals Secret To Make Money With A.I.

He's doing something he's never done before. In ten years, this nerd investor has picked 210+ stocks that have gone up at least 100%.

June 13, 2023 | theglobeandmail.com

Closing Bell: Intellipharmaceutics International Inc down on Monday (IPCI)

April 18, 2023 | finance.yahoo.com

Intellipharmaceutics International Inc. (I4AA.F)

April 7, 2023 | theglobeandmail.com

Closing Bell: Intellipharmaceutics International Inc flat on Wednesday (IPCI)

April 5, 2023 | theglobeandmail.com

Closing Bell: Intellipharmaceutics International Inc flat on Monday (IPCI)

April 4, 2023 | theglobeandmail.com

Closing Bell: Intellipharmaceutics International Inc flat on Friday (IPCI)

February 7, 2023 | yahoo.com

Intellipharmaceutics Provides Update on Management Cease Trade Order Application and Anticipates Cease Trade Order

January 13, 2023 | finance.yahoo.com

Intellipharmaceutics International Inc. (IPCIF)

August 30, 2022 | thestreet.com

Changes at the Top for Endo Could Benefit Its Smaller Partners

August 23, 2022 | reuters.com

Intellipharmaceutics International Inc

July 23, 2022 | finanznachrichten.de

Intellipharmaceutics International Inc.: Intellipharmaceutics Announces Second Quarter 2022 Results

July 21, 2022 | finance.yahoo.com

Intellipharmaceutics Announces Second Quarter 2022 Results

July 15, 2022 | ca.finance.yahoo.com

Stocks in play: Intellipharmaceutics International Inc.

April 14, 2022 | finanznachrichten.de

Intellipharmaceutics International Inc.: Intellipharmaceutics Announces First Quarter 2022 Results

April 14, 2022 | stockhouse.com

Intellipharmaceutics Announces First Quarter 2022 Results

February 28, 2022 | finanznachrichten.de

Intellipharmaceutics International Inc.: Intellipharmaceutics Announces Fiscal Year 2021 Results

January 13, 2022 | finanznachrichten.de

Intellipharmaceutics International Inc.: Intellipharmaceutics Mourns the Death of Valued Board Member Kenneth Eugene Keirstead

January 7, 2022 | nasdaq.com

Intellipharmaceutics International Inc (IPCIF)

October 15, 2021 | finance.yahoo.com

Intellipharmaceutics Announces Third Quarter 2021 Results

See More Headlines

Receive I Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Intellipharmaceutics International and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today: 4/16/2024
Next Earnings (Estimated): 6/04/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: TSE
Sector: Business Services
Industry: Wireless Telecommunications
Sub-Industry: N/A
Current Symbol: TSE:I
CUSIP: N/A
CIK: N/A
Web: www.intelsat.com
Phone: +1-416-7983001
Fax: N/A
Employees: 1,195
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: 30,156,000
Free Float: N/A
Market Cap: C$97.40 million
Optionable: Not Optionable
Beta: N/A

Beginners Guide To Retirement Stocks

Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Key Executives

Isa Odidi Ph.D.
Chairman of the Board, Chief Executive Officer
Amina Odidi Ph.D.
President, Chief Operating Officer, Director
Andrew Patient
Chief Financial Officer
John N. Allport
Vice President - Legal Affairs and Licensing, Secretary, Director
Patrick N. Yat Ph.D.
Vice President - Pharmaceutical Analysis and Chemistry
Kenneth Keirstead
Independent Director
Bahadur Madhani
Independent Director
Eldon R. Smith M.D. (Age 75)
Independent Director

Key Competitors

View All Competitors

I Stock Analysis - Frequently Asked Questions

How have I shares performed in 2024?: Intellipharmaceutics International's stock was trading at C$3.23 at the beginning of the year. Since then, I stock has increased by 0.0% and is now trading at C$3.23.
View the best growth stocks for 2024 here.
When is Intellipharmaceutics International's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Tuesday, June 4th 2024.
View our I earnings forecast.
What other stocks do shareholders of Intellipharmaceutics International own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Intellipharmaceutics International investors own include QuickLogic (QUIK), VBI Vaccines (VBIV), NeuLion (NLN), Micron Technology (MU), Mallinckrodt (MNK), Intellipharmaceutics International (IPCIF), Fitbit (FIT), Clean Commodities (CLE), Calithera Biosciences (CALA) and BlackBerry (BB).
How do I buy shares of Intellipharmaceutics International?: Shares of I stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

This page (TSE:I) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial